These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

98 related items for PubMed ID: 2896125

  • 21. [The action of various doses of the new imidazole H2-receptor antagonist etintidine on intragastric acidity in man].
    Dammann HG, Rehner M, Dreyer M, Walter TA, Müller P, Simon B.
    Arzneimittelforschung; 1986 Nov; 36(11):1699-701. PubMed ID: 2880596
    [Abstract] [Full Text] [Related]

  • 22. Bioequivalence of two oral formulations of nizatidine capsules in healthy male volunteers.
    Lockyer M, Al-Dgither S, Al-Gaai E, Yousuf A, Hammami MM.
    Biopharm Drug Dispos; 2005 Apr; 26(3):117-20. PubMed ID: 15723428
    [Abstract] [Full Text] [Related]

  • 23. Effect of ranitidine on the pharmacokinetics of orally administered eprosartan, an angiotensin II antagonist, in healthy male volunteers.
    Tenero DM, Martin DE, Ilson BE, Boyle DA, Boike SC, Carr AM, Lundberg DE, Jorkasky DK.
    Ann Pharmacother; 1998 Mar; 32(3):304-8. PubMed ID: 9533060
    [Abstract] [Full Text] [Related]

  • 24. Pharmacokinetics and biochemical efficacy after single and multiple oral administration of losartan, an orally active nonpeptide angiotensin II receptor antagonist, in humans.
    Ohtawa M, Takayama F, Saitoh K, Yoshinaga T, Nakashima M.
    Br J Clin Pharmacol; 1993 Mar; 35(3):290-7. PubMed ID: 8471405
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Plasma analysis and pharmacokinetics of zaltidine, an H2-antagonist, in cattle after intravenous, intramuscular, subcutaneous, and oral administration.
    Hunter RP, Canning PC, Hassfurther R.
    J Vet Pharmacol Ther; 1996 Aug; 19(4):326-8. PubMed ID: 8866466
    [No Abstract] [Full Text] [Related]

  • 32. Effect of renal impairment on the pharmacokinetics of cibenzoline.
    Massarella JW, Khoo KC, Aogaichi K, Di Persio D, Smith M, Kluger J, Chow MS.
    Clin Pharmacol Ther; 1988 Mar; 43(3):317-23. PubMed ID: 3345622
    [Abstract] [Full Text] [Related]

  • 33. Famotidine pharmacokinetics following oral and intravenous administration in patients with liver disease: results of a preliminary study.
    Morgan MY, Stambuk D.
    Postgrad Med J; 1986 Mar; 62 Suppl 2():29-37. PubMed ID: 2890149
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Pharmacokinetics of CM 57755, a new histamine H2-receptor antagonist, after single oral doses in man.
    Necciari J, Mery D, Garriot P, Escourrou J, Cautreels W.
    Int J Clin Pharmacol Res; 1985 Mar; 5(6):457-65. PubMed ID: 2869002
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.